Cardiac Amyloid Detection by PET/CT Imaging of Iodine (124I) Evuzamitide (124I-p5+14)

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

(2023) Michelle M. Kittleson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

In the thick of it: hereditary cardiac amyloidosis identified by 124I-AT-01 PET imaging but not cardiac MRI or SPECT 99mTc pyrophosphate scintigraphy

(2023) Dia Smiley et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging

(2023) Emily B. Martin et al.   Pharmaceuticals

Cardiac microcalcifications in transthyretin (ATTR) amyloidosis

(2022) Ulrika Thelander et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Transthyretin cardiac amyloidosis

(2022) Aldostefano Porcari et al.   CARDIOVASCULAR RESEARCH

Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis

(2022) Adam Ioannou et al.   JACC-Cardiovascular Imaging

Cardiac Magnetic Resonance–Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid

(2021) Liza Chacko et al.   Circulation-Cardiovascular Imaging

FALSE NEGATIVE 99MTC-PYROPHOSPHATE SCINTIGRAPHY IN A CASE OF HEREDITARY VARIANT TRANSTHYRETIN (ATTRV) CARDIAC AMYLOIDOSIS

(2021) Dan ‘Leslie’ Li et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution

(2021) Yuki Tateishi et al.   PATHOLOGY RESEARCH AND PRACTICE

Cardiac Amyloidosis: A Review of Current Imaging Techniques

(2021) Yousuf Razvi et al.   Frontiers in Cardiovascular Medicine

Systemic amyloidosis from A (AA) to T (ATTR): a review

(2020) E. Muchtar et al.   JOURNAL OF INTERNAL MEDICINE

Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples

(2020) Surendra Dasari et al.   MAYO CLINIC PROCEEDINGS

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging

(2019) Sharmila Dorbala et al.   JOURNAL OF NUCLEAR CARDIOLOGY

How to Image Cardiac Amyloidosis

(2019) Sharmila Dorbala et al.   JACC-Cardiovascular Imaging

CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy

(2018) Ana Martinez-Naharro et al.   JACC-Cardiovascular Imaging

The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease

(2018) Yi-Chun Tsai et al.   PLoS One

Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer

(2017) Amy V. Chudgar et al.   RADIOGRAPHICS

ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers

(2016) Milena J. Henzlova et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis

(2016) Emily B. Martin et al.   Scientific Reports

Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis

(2015) Jonathan Wall et al.   MOLECULES